Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD

PURPOSE: Due to the burden of COPD in Japan, new pharmacologic treatments are needed to meet patient requirements. This study assessed the efficacy and safety of glycopyrronium (GP) delivered via metered dose inhaler (MDI) in Japanese patients with moderate-to-severe COPD. METHODS: This Phase IIb, m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Chron Obstruct Pulmon Dis
Main Authors: Fukushima, Yasushi, Nakatani, Yuji, Ide, Yumiko, Sekino, Hisakuni, St Rose, Earl, Siddiqui, Shahid, Maes, Andrea, Reisner, Colin
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905841/
https://ncbi.nlm.nih.gov/pubmed/29695902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S159246
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados